Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for mitigation and/or treatment of pneumonitis/pneumonia/pulmonary fibrosis induced by virus infection and/or by chemical or biological agents

Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for mitigation and/or treatment of pneumonitis/pneumonia/pulmonary fibrosis induced by virus infection and/or by chemical or biological agents

US Patent 11672772 · Granted Jun 13, 2023

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Materials and methods for improving gastrointestinal function2025
Materials and methods for improving gastrointestinal function2023
Materials and methods for improving gastrointestinal function2021
Materials and methods for improving gastrointestinal function2019
Materials and methods for treatment of cystic fibrosis and for induction of ion 2018
Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for preventi2016
Materials and methods for improving gastrointestinal function2015
Fibroblast growth factor (FGF) analogs and uses thereof2014
Method for predicting the level of damage to cells by measuring free circulating2013